A prospective comparison for suspected scaphoid fractures: bone scintigraphy versus clinical outcome.
Early diagnosis and treatment of scaphoid fractures limits the number of delayed and non-unions. Bone scintigraphy proved to be a sensitive diagnostic tool for the detection of occult scaphoid fractures. However, the results have to be interpreted with care.


OBJECTIVE
To prospectively correlate the results of bone scintigraphy with clinical outcome.


METHODS
In a prospective study, we analysed 50 consecutive patients with signs of a scaphoid fracture at physical examination but no evidence of a scaphoid fracture on scaphoid radiographs. All patients had a protocolised follow up at fixed intervals. The clinical outcome was defined according to a standardised algorithm.


RESULTS
Bone scintigraphy revealed 32% (16/50) occult scaphoid fractures and 40% (20/50) occult other fractures. Clinical outcome proved that bone scintigraphy was false positive in five patients and in one case false negative for a scaphoid fracture.


CONCLUSIONS
Bone scintigraphy in combination with protocolised physical examination is the gold standard for patients with signs of a scaphoid fracture that cannot be proven on scaphoid radiographs.
Beeres
F J P
FJ
Department of Surgery, Medisch Centrum Haaglanden, The Hague, The Netherlands. f.j.p.beeres@lumc.nl
Hogervorst
M
M
Rhemrev
S J
SJ
den Hollander
P
P
Jukema
G N
GN
D000328:Adult; D000368:Aged; D004164:Diphosphonates; D005260:Female; D050723:Fractures, Bone / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D021361:Scaphoid Bone / Q000000981:diagnostic imaging / Q000293:injuries*; D017556:Technetium Compounds; D016896:Treatment Outcome
D004164:Diphosphonates; D019275:Radiopharmaceuticals; D017556:Technetium Compounds; C029045:technetium Tc 99m diphosphonate